eXoZymes

Yahoo Finance • 2 days ago

eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast

LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced that Ch... Full story

Yahoo Finance • 8 months ago

Earnings call transcript: eXoZymes' Q2 2025 focuses on innovation and partnerships

eXoZymes Inc reported its Q2 2025 financial performance, revealing a net loss of $2.36 million and year-to-date losses of $4.22 million. The company maintains a strong cash position with $6.99 million, ensuring liquidity into 2026. Accordi... Full story

Yahoo Finance • 10 months ago

InvestingPro Fair Value model correctly predicts eXoZymes' 40% price drop

In a compelling demonstration of analytical precision, Investing.com’s Fair Value model successfully identified significant overvaluation in eXoZymes Inc. (NASDAQ:EXOZ) shares in December 2024. The subsequent price movement has validated t... Full story

Yahoo Finance • 12 months ago

Bringing clarity and precision to the cell-free space by introducing exozymes

Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free biomanufa... Full story

Yahoo Finance • last year

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals... Full story

Yahoo Finance • last year

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus on developing commercial opportunities,... Full story

Yahoo Finance • last year

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock i... Full story

Yahoo Finance • last year

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

Monrovia, CA , March 26, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ) [“eXoZymes”] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels - plans to host a... Full story

Yahoo Finance • last year

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced... Full story